Global Biologics Safety Testing Industry Size study, By Players (Merck KGaA, Lonza Group Ltd., WuXi Apptec), By Product (Instruments, Services, Kits & Reagents) and By Type (Endotoxin, Sterility Test, Cell Line Authentication, Bioburden)- Analysis and Current Growth Analysis 2018 - 2025
Product Code: RP-ID-10078424 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10078424
Market Overview:
Global Biologics Safety Testing Industry Size study, By Players (Merck KGaA, Lonza Group Ltd., WuXi Apptec), By Product (Instruments, Services, Kits & Reagents) and By Type (Endotoxin, Sterility Test, Cell Line Authentication, Bioburden)- Analysis and Current Growth Analysis 2018 - 2025
Global Biologics Safety Testing Industry valued approximately USD 2.40 billion in 2016 is anticipated to grow with a healthy growth rate of more than 13.39% over the forecast period 2017-2025. The factors speculated to propel the Industry are the surge in number launches of new drugs, and the development in biotechnology & pharmaceutical industry owing to the government encouragement in these industries.
The objective of the study is to define Industry sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the Industry. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players.
Major market players in Biologics Safety Testing Industry are Merck KGaA, Lonza Group Ltd., WuXi Apptec, Charles River Laboratories, Sartorius AG, SGS SA, Thermo Fisher Scientific Inc., and Pace Analytical Services Inc.
Biologics Safety Testing Industry Segmentation:
By Product:
• Instruments
• Services
• Kits & Reagents
By Test:
• Endotoxin
• Sterility Test
• Cell Line Authentication
• Bioburden
• Others
By Application:
• Vaccine & Therapeutics Development
• Blood Products Testing
• Stem Cell Research
• Cellular & Gene Therapy
• Tissue Related Product Testing
By Region:
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
Related Reports
Study Period : 2023-2035
Report Format : PDF,PPT
Delivery Timeline : 48-72 Business Hours
Proof of Quality & Reliability
